Delivery Order SPE2DB24D2003-SPE2DB25FXHX2

Award Date 5/21/25
Potential Completion Date 5/22/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $7,377.12, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 11, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,619.55, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 22, 2025. The contract is a delivery order with a firm fixed price and has an ultimate completion date of May 23, 2025. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $7,804.29 to provide MULTAQ 400 MG TABLET 60S. The contract is with the Defense Logistics Agency (DLA) and has an ultimate completion date of April 8, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $22,862.40 and is a Firm Fixed Price Delivery Order with a completion date of December 13, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S to the Defense Logistics Agency (DLA). The contract, valued at $5,133.55, was awarded to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 2, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,576.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a completion date of February 21, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $7,138.27 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 12, 2023. The contract has an ultimate completion date of December 13, 2023 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S pharmaceutical products. The $3,207.06 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 18, 2025. The contract has a ceiling value of $3,207.06 and an ultimate completion date of February 19, 2025. This contract is not associated with any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor...
This federal contract award is for the delivery of 4566374215 MULTAQ 400 MG TABLET 60S to the Defense Logistics Agency (DLA) Troop Support Medical. The $20,357.36 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 8, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,614.25 firm fixed-price delivery order contract is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of October 11, 2023 and was awarded on October 10, 2023. This delivery order contract is part of a larger $999,999,999 Indefinite Delivery Contract...
  • SPE2DB24D2003
    Indefinite Delivery Contract
  • SPE2DB24D2003-SPE2DB25FXHX2
    Delivery Order

This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $2,039.84 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 21, 2025, with a completion date of May 22, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, which enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract is not designated as a set-aside.

Generated 8/20/25, 9:47 AM